MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.transproceed.2022.02.035

Медицинская библиотека · Transplantation proceedings · 2022

Assessment of the Serologic Status in Epstein-Barr Virus in Patients Qualified for Lung Transplantation in the First Half of 2021.

Stanjek-Cichoracka Anita, Łaszewska Anna, Woźniak-Grygiel Elżbieta, Nęcki Mirosław, Latos Magdalena, Zawadzki Fryderyk, Ochman Marek

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

The aim of the study was to assessment serologic status of Epstein-Barr virus (EBV) infections in patients qualificated for lung transplantation in the first half of 2021.

METHODS

The study included 72 patients qualified for lung transplantation from January to June 2021. The youngest patient was aged 14 years and the oldest was aged 65 years. The study group consisted of 36 women and 36 men. In the serum of patients, a multi-parameter, comprehensive diagnosis of EBV infections was performed using the IIFT BIOCHIP EBV sequence tests. This test is based on a combination of several substrates, enabling the simultaneous evaluation of antibodies against capsid antigens (anti-CA antibodies), both in the IgG and IgM class, early antigens (anti-EA), nuclear antigens and the assessment of the avidity of anti-CA antibodies. The analysis of all diagnostically significant antibodies specific for EBV infections, including the avidity of anti-CA antibodies, increases the diagnostic accuracy in differentiating active and past infection with EBV.

RESULTS

In the studied group it was shown that 58 had past EBV infection (80.6%). Twelve patients (16.6%) have anti-EA antibodies, which indicate that the virus is reactivated. Only 2 patients (2.8%) had no antibodies to EBV.

CONCLUSIONS

Comprehensive assessment of antibodies against various EBV antigens in patients qualified for lung transplantation is important in the management and further diagnosis of this infection, especially after transplantation, due to the risk of developing post-transplant lymphoproliferative disease.

Для цитирования: Stanjek-Cichoracka Anita, Łaszewska Anna, Woźniak-Grygiel Elżbieta, Nęcki Mirosław, Latos Magdalena, Zawadzki Fryderyk, Ochman Marek. Assessment of the Serologic Status in Epstein-Barr Virus in Patients Qualified for Lung Transplantation in the First Half of 2021.. Transplantation proceedings. 2022. DOI: 10.1016/j.transproceed.2022.02.035.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.